REG - CVS Group plc - Director/PDMR Shareholding

CVSAnnouncement

07/01/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250107:nRSG3169Sa&default-theme=true

RNS Number : 3169S  CVS Group plc  07 January 2025

7 January 2025

 

CVS Group plc

 

("CVS" or the "Company")

 

PDMR Dealing

CVS, one of the UK's leading providers of integrated veterinary services,
announces that it was made aware on 6 January 2025 that, as part of a dividend
reinvestment plan, Joanne Shaw, Non-executive Director, purchased 14 ordinary
shares of £0.002 each ("Ordinary Shares") at a price of 840.25 pence per
Ordinary Share on 29 November 2024. Following this transaction, she holds a
total of 1,562 Ordinary Shares, representing approximately 0.002% of the
current Issued Share Capital of the Company.

The notification below, made in accordance with the requirements of the UK
Market Abuse Regulation, provides further detail.

Contacts:

CVS Group
plc
via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker)
                                               +44
(0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

   Berenberg (Joint Broker)
 
                   +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey Pelham-Lane
 
                   +44 (0)7733 124 226

Ginny Pulbrook
 
                          +44 (0)7961 315 138

 

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Joanne Shaw

 2    Reason for the notification

 a)   Position/status                                              PDMR (Non-Executive Director)

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CVS Group plc

 b)   LEI                                                          213800J41XDQ2NX48O05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

      Identification code

                                                                   GB00B2863827

 b)   Nature of the transaction                                    On-market purchase

 c)   Price(s) and volume(s)

Price(s) - pence  Volume(s)

                                                                   840.25            14

 

 d)   Aggregated information

      - Aggregated volume

                                                                   N/A - single transaction

      - Price

 e)   Date of the transaction                                      29 November 2024

 f)   Place of the transaction                                     London Stock Exchange - AIM (XLON)

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

N/A - single transaction

e)

 

Date of the transaction

 

 

29 November 2024

f)

 

Place of the transaction

 

London Stock Exchange - AIM (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHEAFFKEFDSEAA